Paper39201617
Nanoparticles-Delivered Circular RNA Strategy as a Novel Antitumor Approach.
Racca L and 4 others. Int J Mol Sci, 2024. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Nanoparticles-Delivered Circular RNA Strategy as a Novel Antitumor Approach. Papers, record 39201617. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201617
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| RNA, Circular | Major topic |
| Neoplasms | Major topic |
| Nanoparticles | Major topic |
| Humans | |
| Animals | |
| Genetic Therapy | |
| Antineoplastic Agents |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ROL 76069-2021 | Fondazione CRT | PubMed |
Source PubMed
References136
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30717751 | Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. | Mol Cancer | 2019 | https://conductscience.org/library/papers/30717751 | PubMed |
| 2 | 30537986 | A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1. | Genome Biol | 2018 | https://conductscience.org/library/papers/30537986 | PubMed |
| 3 | 30794990 | Epidermal growth factor-nanoparticle conjugates change the activity from anti-apoptotic to pro-apoptotic at membrane rafts. | Acta Biomater | 2019 | https://conductscience.org/library/papers/30794990 | PubMed |
| 4 | 31185953 | Silencing of ANKRD12 circRNA induces molecular and functional changes associated with invasive phenotypes. | BMC Cancer | 2019 | https://conductscience.org/library/papers/31185953 | PubMed |
| 5 | 38282696 | Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer. | Noncoding RNA Res | 2024 | https://conductscience.org/library/papers/38282696 | PubMed |
| 6 | 36982236 | Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982236 | PubMed |
| 7 | 29456858 | Enhanced biostability and cellular uptake of zinc oxide nanocrystals shielded with a phospholipid bilayer. | J Mater Chem B | 2017 | https://conductscience.org/library/papers/29456858 | PubMed |
| 8 | 33277608 | Engineering precision nanoparticles for drug delivery. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33277608 | PubMed |
| 9 | 37056563 | Nanoparticle formulations for therapeutic delivery, pathogen imaging and theranostic applications in bacterial infections. | Theranostics | 2023 | https://conductscience.org/library/papers/37056563 | PubMed |
| 10 | 36797769 | Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-𝜅B-IL-6 axis of tumor-associated macrophages. | J Exp Clin Cancer Res | 2023 | https://conductscience.org/library/papers/36797769 | PubMed |
| 11 | 25664725 | Exon-intron circular RNAs regulate transcription in the nucleus. | Nat Struct Mol Biol | 2015 | https://conductscience.org/library/papers/25664725 | PubMed |
| 12 | 34684252 | Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis. | Pathogens | 2021 | https://conductscience.org/library/papers/34684252 | PubMed |
| 13 | 31901148 | Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer. | Mol Oncol | 2020 | https://conductscience.org/library/papers/31901148 | PubMed |
| 14 | 34927541 | Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression. | Bioengineered | 2021 | https://conductscience.org/library/papers/34927541 | PubMed |
| 15 | 29581865 | Luminal breast cancer-specific circular RNAs uncovered by a novel tool for data analysis. | Oncotarget | 2018 | https://conductscience.org/library/papers/29581865 | PubMed |
| 16 | 25242144 | circRNA biogenesis competes with pre-mRNA splicing. | Mol Cell | 2014 | https://conductscience.org/library/papers/25242144 | PubMed |
| 17 | 37020690 | Nanoparticles Mediated circROBO1 Silencing to Inhibit Hepatocellular Carcinoma Progression by Modulating miR-130a-5p/CCNT2 Axis. | Int J Nanomedicine | 2023 | https://conductscience.org/library/papers/37020690 | PubMed |
| 18 | 27886165 | Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. | Cell Death Differ | 2017 | https://conductscience.org/library/papers/27886165 | PubMed |
| 19 | 37296107 | CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37296107 | PubMed |
| 20 | 33896342 | A promising dual-drug targeted delivery system in cancer therapy: nanocomplexes of folate-apoferritin-conjugated cationic solid lipid nanoparticles. | Pharm Dev Technol | 2021 | https://conductscience.org/library/papers/33896342 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42780376 | Emerging strategies and innovations in circular RNA synthesis. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42780376 | PubMed |
| 41799520 | Circular RNAs: Key Regulators of Tumor Metabolic Reprogramming and Clinical Translation. | Oncol Res | 2026 | https://conductscience.org/library/papers/41799520 | PubMed |
| 41632314 | Circular RNAs: key regulators in cancer stem cell dynamics. | Mol Genet Genomics | 2026 | https://conductscience.org/library/papers/41632314 | PubMed |
| 41353994 | Circular RNAs in cancer immunology: Immune escape, therapeutic resistance, and nanomedicine synergies. | Transl Oncol | 2026 | https://conductscience.org/library/papers/41353994 | PubMed |
| 41299798 | Exploring the role of circular RNAs in endometrial cancer progression and chemoresistance: Implications for targeted therapies. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/41299798 | PubMed |
| 41141671 | Advances in the research on circular RNA in pediatric pancreatic tumors. | Transl Pediatr | 2025 | https://conductscience.org/library/papers/41141671 | PubMed |
| 40945848 | Decoding the functional network of circular RNAs encoding proteins in hepatocellular carcinoma: from carcinogenesis to clinical transformation. | J Adv Res | 2026 | https://conductscience.org/library/papers/40945848 | PubMed |
| 39901896 | Circular RNAs in cancer. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/39901896 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39201617
GET https://conductscience.org/api/papers/v1/39201617/references?page=2